Enzymes Practice Questions

Q: Which of the following statements regarding Nitric Oxide Synthase is correct?

It requires NADPH, FAD, FMN, and heme iron. **Explanation:** **Nitric Oxide Synthase (NOS)** is a complex enzyme responsible for synthesizing Nitric Oxide (NO) from the amino acid **L-arginine**. **1. Why Option D is Correct:** NOS is a unique enzyme that functions as both a reductase and an oxygenase. To catalyze the conversion of L-arginine to L-citrulline and NO, it requires five essential cofactors: **NADPH, FAD, FMN, Heme iron (protoporphyrin IX), and Tetrahydrobiopterin (BH4)**. The electrons flow from NADPH through the flavins (FAD/FMN) to the heme center, where oxygen is reduced and incorporated into the substrate. **2. Why Other Options are Incorrect:** * **Option A:** NOS (specifically the eNOS and nNOS isoforms) is actually **activated by Calcium-Calmodulin** binding, not inhibited by it. * **Option B:** It catalyzes a **monooxygenase** reaction. In the process, one atom of oxygen is incorporated into the hydroxyl group of the intermediate (L-hydroxyarginine), and the other is reduced to water. * **Option C:** The primary electron donor for NOS is **NADPH**, not NADH. **3. High-Yield Clinical Pearls for NEET-PG:** * **Isoforms:** There are three isoforms: **nNOS** (neuronal/Type I), **iNOS** (inducible/Type II), and **eNOS** (endothelial/Type III). * **iNOS:** Unlike the others, iNOS is **calcium-independent** and is expressed in macrophages during inflammation to produce large amounts of NO for bactericidal activity. * **Substrate:** L-arginine is the precursor; L-citrulline is the byproduct. * **Inhibitor:** Asymmetric dimethylarginine (ADMA) acts as an endogenous inhibitor of NOS.

Q: Which of the following enzymes does not contain Cu2+?

Xanthine oxidase. **Explanation:** The correct answer is **Xanthine oxidase** because it is a metalloenzyme that requires **Molybdenum (Mo)**, Iron (Fe), and FAD as cofactors, rather than Copper (Cu²⁺). It plays a critical role in purine catabolism by converting hypoxanthine to xanthine and xanthine to uric acid. **Analysis of Options:** * **Ceruloplasmin (Option A):** This is the primary copper-carrying protein in the blood. It contains 6 to 8 copper atoms per molecule and functions as a ferroxidase, converting Fe²⁺ to Fe³⁺ for binding to transferrin. * **Cytochrome Oxidase (Option B):** Also known as Complex IV of the Electron Transport Chain, it contains two copper centers ($Cu_A$ and $Cu_B$) along with heme groups ($a$ and $a_3$). It is essential for transferring electrons to oxygen. * **Dopamine beta-hydroxylase (Option C):** This enzyme converts dopamine to norepinephrine in the catecholamine synthesis pathway. It requires **Copper** and Vitamin C (ascorbic acid) as essential cofactors. **High-Yield Clinical Pearls for NEET-PG:** * **Menkes Disease:** A defect in copper absorption (ATP7A) leading to "kinky hair" and neurological issues due to the failure of copper-dependent enzymes like Lysyl oxidase and Dopamine $\beta$-hydroxylase. * **Wilson Disease:** A defect in copper biliary excretion (ATP7B) leading to low serum ceruloplasmin and copper deposition in the liver and basal ganglia (Kayser-Fleischer rings). * **Other Copper Enzymes:** Lysyl oxidase (collagen cross-linking), Tyrosinase (melanin synthesis), and Superoxide Dismutase (cytosolic antioxidant). * **Xanthine Oxidase Inhibitor:** Allopurinol and Febuxostat are used to treat Gout by inhibiting this molybdenum-containing enzyme.

Q: Lysosomal enzymes are maximally active at which pH?

Acidic pH. **Explanation:** Lysosomes are membrane-bound organelles often referred to as the "suicide bags" of the cell. They contain approximately 50 different degradative enzymes known as **acid hydrolases** (e.g., phosphatases, glycosidases, proteases, and lipases). **1. Why Acidic pH is Correct:** The enzymes within lysosomes are specifically designed to function at an **optimum pH of approximately 4.5 to 5.0**. This acidity is maintained by a **V-type ATPase (proton pump)** located in the lysosomal membrane, which actively pumps H+ ions from the cytosol into the lysosome. This acidic environment is crucial for the denaturation of macromolecules, making them easier for hydrolases to degrade. **2. Why Other Options are Incorrect:** * **Alkaline & Neutral pH:** Most cytosolic and extracellular enzymes function best at a physiological pH (~7.2–7.4). If lysosomal enzymes were active at a neutral or alkaline pH, any accidental leakage or rupture of a lysosome would lead to the immediate autodigestion of the cell's vital components. * **No relation with pH:** Enzyme activity is strictly dependent on the ionization state of the amino acids at the active site, which is directly influenced by pH. **High-Yield Clinical Pearls for NEET-PG:** * **Protective Mechanism:** The requirement for an acidic pH serves as a protective mechanism for the cell; if a lysosome leaks, the hydrolases become inactive in the neutral cytosol, preventing cellular damage. * **I-Cell Disease:** A high-yield pathology where lysosomal enzymes fail to be phosphorylated (Man-6-P tag) in the Golgi, leading to their secretion outside the cell rather than being targeted to the lysosome. * **Lysosomal Storage Disorders (LSDs):** Deficiencies in specific acid hydrolases lead to the accumulation of undigested substrates (e.g., Gaucher’s, Tay-Sachs, and Niemann-Pick disease).

Q: In transaminases, Pyridoxal Phosphate (PLP) is covalently attached to which amino acid?

Lysine. **Explanation:** In transamination reactions, **Pyridoxal Phosphate (PLP)**, the active form of Vitamin B6, serves as an essential coenzyme. The correct answer is **Lysine** because PLP is covalently bound to the enzyme (transaminase/aminotransferase) at its active site via a specific linkage called a **Schiff base** (aldimine linkage). This bond forms between the aldehyde group of PLP and the **$\epsilon$-amino group** of a specific Lysine residue within the enzyme. During the reaction, the substrate amino acid displaces this lysine to form a new Schiff base with PLP. **Analysis of Incorrect Options:** * **A. Glutamate:** While glutamate is a frequent product or reactant in transamination (acting as the universal amino group collector), it does not provide the covalent attachment site for the coenzyme. * **C. Alanine:** Alanine is a substrate for ALT (Alanine Transaminase) but does not participate in the structural binding of PLP to the enzyme. * **D. Threonine:** Threonine is one of the few amino acids (along with Lysine) that **does not** undergo transamination; it is instead deaminated by dehydratases. **High-Yield Clinical Pearls for NEET-PG:** * **Vitamin B6 Deficiency:** Leads to decreased transaminase activity, manifesting as convulsions (due to decreased GABA synthesis) and sideroblastic anemia. * **Non-transaminating Amino Acids:** Remember the mnemonic **"KLT"** (Lysine, Leucine, Threonine) — these do not participate in transamination. * **Diagnostic Markers:** AST (SGOT) and ALT (SGPT) are key biomarkers for liver and cardiac injury; both require PLP as a cofactor. * **Other PLP-dependent reactions:** Decarboxylation (e.g., Histidine to Histamine), Heme synthesis (ALA synthase), and Cystathionine synthesis.

Q: Zinc is an essential component of which of the following enzymes?

Xanthine oxidase. **Explanation:** The question focuses on the essential metal cofactors required for enzyme activity, a high-yield topic in Biochemistry. **Correct Answer: C. Xanthine Oxidase** Xanthine oxidase is a complex metalloenzyme that requires **Molybdenum (Mo)**, **Iron (Fe)**, and **Flavin (FAD)** for its catalytic activity. It plays a critical role in purine catabolism by converting hypoxanthine to xanthine and xanthine to uric acid. *(Note: There appears to be a discrepancy in the question stem provided; while Zinc is a common cofactor for many enzymes, Xanthine Oxidase specifically requires Molybdenum. In the context of standard NEET-PG patterns, if the question asks for Zinc, options A, B, and D are actually the correct associations, whereas C is the outlier).* **Analysis of Other Options (Zinc-containing Enzymes):** Zinc is a constituent of over 300 enzymes. The following are classic examples: * **A. Carbonic Anhydrase:** Contains Zinc at its active site; it is essential for the transport of $CO_2$ and acid-base balance. * **B. Alkaline Phosphatase (ALP):** A Zinc-metalloenzyme used clinically as a marker for cholestasis and bone turnover. * **D. Alcohol Dehydrogenase:** Requires Zinc to oxidize ethanol into acetaldehyde in the liver. **High-Yield Clinical Pearls for NEET-PG:** * **Molybdenum:** Remember the "Moly" connection—**Xanthine Oxidase** and **Sulfite Oxidase**. Deficiency leads to hyperoxanthinemia and urinary stones. * **Zinc Deficiency:** Presents as **Acrodermatitis enteropathica**, poor wound healing, hypogeusia (loss of taste), and growth retardation. * **Other Metal Cofactors:** * **Selenium:** Glutathione peroxidase. * **Copper:** Cytochrome c oxidase, Superoxide dismutase (cytosolic), and Tyrosinase. * **Manganese:** Pyruvate carboxylase.

Q: Enzymes act by reducing which of the following?

Activation energy. ### Explanation **1. Why Activation Energy is Correct:** In any biochemical reaction, substrates must reach a high-energy, unstable state known as the **Transition State** before they can be converted into products. The energy required to reach this state is called the **Activation Energy ($E_a$)**. Enzymes function as biological catalysts by stabilizing the transition state and providing an alternative reaction pathway. This significantly **lowers the activation energy barrier**, allowing more substrate molecules to have sufficient energy to react at body temperature, thereby increasing the reaction rate. **2. Why Other Options are Incorrect:** * **Binding Energy:** This is the energy released when the enzyme interacts with its substrate through non-covalent bonds. Enzymes actually **maximize** binding energy to stabilize the transition state; they do not reduce it. * **Heat Energy:** Enzymes do not reduce heat energy; in fact, they allow reactions to occur efficiently at a constant physiological temperature (37°C) without requiring an increase in thermal energy. * **Covalent Energy:** This refers to the energy within chemical bonds. While enzymes may form transient covalent bonds (covalent catalysis), they do not "reduce" covalent energy as a mechanism of action. **3. NEET-PG High-Yield Pearls:** * **Thermodynamics:** Enzymes change the **rate** of the reaction but **do not** alter the equilibrium constant ($K_{eq}$) or the standard free energy change ($\Delta G$). * **Transition State:** Enzymes have the highest affinity for the **transition state** of the substrate, not the substrate itself (Linus Pauling’s principle). * **Michaelis-Menten Kinetics:** A lower $K_m$ indicates a higher affinity of the enzyme for its substrate. * **Clinical Correlation:** Many drugs act as enzyme inhibitors (e.g., Statins inhibit HMG-CoA reductase) by interfering with the enzyme's ability to lower activation energy.

Q: Sulfonamides inhibit bacterial synthesis of folic acid by:

Competitive inhibition. ### Explanation **1. Why Competitive Inhibition is Correct:** Sulfonamides (Sulfa drugs) are structural analogs of **Para-Aminobenzoic Acid (PABA)**. In bacteria, the enzyme **Dihydropteroate Synthase** normally uses PABA as a substrate to synthesize folic acid. Because sulfonamides closely resemble PABA in structure, they compete for the same active site on the enzyme. By binding to the active site, sulfonamides prevent PABA from binding, thereby halting folic acid synthesis. Since humans obtain folic acid from their diet and do not synthesize it intracellularly, this mechanism selectively targets bacteria. **2. Why Other Options are Incorrect:** * **Uncompetitive Inhibition:** The inhibitor binds only to the enzyme-substrate (ES) complex, not the free enzyme. Sulfonamides bind to the free enzyme. * **Allosteric Inhibition:** The inhibitor binds to a site other than the active site (allosteric site), causing a conformational change. Sulfonamides compete directly for the active site. * **Non-competitive Inhibition:** The inhibitor binds to a site distinct from the active site, and its effect cannot be overcome by increasing substrate concentration. Competitive inhibition (like sulfonamides) *can* be reversed by increasing the concentration of PABA. **3. High-Yield Clinical Pearls for NEET-PG:** * **Kₘ and Vₘₐₓ:** In competitive inhibition, **Kₘ increases** (affinity decreases) while **Vₘₐₓ remains unchanged**. * **Sequential Blockade:** Trimethoprim is often combined with Sulfamethoxazole (Cotrimoxazole) to inhibit the next step in the pathway (Dihydrofolate Reductase), providing a synergistic effect. * **Other Competitive Inhibitors:** * **Statins** (compete with HMG-CoA) * **Methotrexate** (competes with Dihydrofolate) * **Methanol poisoning treatment:** Ethanol/Fomepizole (compete for Alcohol Dehydrogenase).

Question 1

Serum alkaline phosphatase is elevated in which of the following conditions?

Accepted Answer

Primary biliary cirrhosis

Answer

Hypophosphatemia

Answer

Hyperphosphatemia

Answer

Hepatitis A

Question 2

Which of the following statements regarding Nitric Oxide Synthase is correct?

Accepted Answer

It requires NADPH, FAD, FMN, and heme iron

Answer

It is inhibited by Ca+

Answer

It catalyzes a dioxygenase reaction

Answer

It accepts electrons from NADH

Question 3

Which of the following enzymes does not contain Cu2+?

Accepted Answer

Xanthine oxidase

Answer

Ceruloplasmin

Answer

Cytochrome Oxidase

Answer

Dopamine beta-hydroxylase

Question 4

Lysosomal enzymes are maximally active at which pH?

Accepted Answer

Acidic pH

Answer

Alkaline pH

Answer

Neutral pH

Answer

Has no relation with pH

Question 5

In transaminases, Pyridoxal Phosphate (PLP) is covalently attached to which amino acid?

Accepted Answer

Lysine

Answer

Glutamate

Answer

Alanine

Answer

Threonine

Question 6

Zinc is an essential component of which of the following enzymes?

Accepted Answer

Xanthine oxidase

Answer

Carbonic anhydrase

Answer

Alkaline phosphatase

Answer

Alcohol dehydrogenase

Question 7

Enzymes act by reducing which of the following?

Accepted Answer

Activation energy

Answer

Binding energy

Answer

Heat energy

Answer

Covalent energy

Question 8

Sulfonamides inhibit bacterial synthesis of folic acid by:

Accepted Answer

Competitive inhibition

Answer

Uncompetitive inhibition

Answer

Allosteric inhibition

Answer

Non-competitive inhibition

Question 9

Increased serum acid phosphatase is a laboratory finding of which condition?

Accepted Answer

Osteopetrosis

Answer

Hyperparathyroidism

Answer

Fibrous dysplasia

Answer

Scurvy

Question 10

Allosteric enzymes show the following characteristics, except?

Accepted Answer

Effector site overlap with the active site

Answer

Co-operative binding of substrate

Answer

Obey Sigmoid saturation kinetics

Answer

Active site and effector site need not be located on the same subunit

Enzymes — MCQs

Enzymes — MCQs

On this page

Practice by Chapter

Want unlimited practice?